Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Insignia Systems, Inc. Announces 2022 Second Quarter And Six-month Financial Results
-
Wag! Announces Closing of Business Combination with CHW Acquisition Corporation
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form 8-K Chardan NexTech Acquisit For: Aug 08
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Dragonfly Energy and Chardan NexTech Acquisition 2 Corp. to Host Fireside Chat Today with IPO Edge to Discuss Business Combination
-
uniQure Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form 8-K Chardan NexTech Acquisit For: Aug 05
-
Nauticus Robotics Announces Contract with Shell for Autonomous Method of Subsea Operations
-
Chardan NexTech Acquisition 2 Corp. Increases Deposit Amount to Trust Account Related to Business Combination Extension
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form DEFA14A Chardan NexTech Acquisit
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Duddell Street Acquisition Corp. and FiscalNote Complete Business Combination
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Chardan NexTech Acquisition 2 Corp. Announces Extraordinary General Meeting to Amend Charter
-
Form DEFA14A Chardan NexTech Acquisit
-
Form RW Chardan NexTech Acquisit
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Dragonfly Energy's CEO Dr. Denis Phares Presented on Need for Safe, Affordable Energy Storage at TEDXReno
-
Ventoux CCM Acquisition (VTAQ) and Presto Automation Announces $100M Raise, Revised $525M Valuation
-
Ventoux CCM and Presto Automation Announce $100 Million Raise, Revised Valuation
-
Form DEF 14A Chardan NexTech Acquisit For: Aug 05
-
Form S-4 Chardan NexTech Acquisit
-
Form RW Chardan NexTech Acquisit
-
Aqua Metals and Dragonfly Announce LOI to Supply Lithium Hydroxide to Dragonfly Energy in Ongoing Development of Solid-State Li-ion Batteries
-
UPDATE: Chardan Capital Markets Starts Dyne Therapeutics (DYN) at Buy
-
UPDATE: Chardan Capital Markets Starts Avidity Biosciences (RNA) at Buy
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Dragonfly Energy to Host Virtual Analyst & Investor Day On August 5, 2022
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form 8-K Chardan NexTech Acquisit For: Jul 13
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
Form 8-K Chardan NexTech Acquisit For: Jul 12
-
Thor Industries (THO) Acquires Stake in Dragonfly Energy (CNTQ)
-
THOR Industries Announces Strategic Investment in Dragonfly Energy
-
Form S-4/A Chardan NexTech Acquisit
-
Form PRER14A Chardan NexTech Acquisit
-
UPDATE: Chardan Capital Markets Starts Immuneering Corporation (IMRX) at Buy
-
Orchestra BioMed Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2 (HSAQ)
-
Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2
-
Form PRE 14A Chardan NexTech Acquisit For: Jun 29
-
Yotta Acquisition Corporation Announces the Separate Trading of its Common Stock, Warrants and Rights, Commencing June 27, 2022
-
IROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED DIRECTOR CANDIDATES FOR ELECTION AT PHARMACYTE'S 2022 ANNUAL MEETING
-
Chardan NexTech Acquisition 2 Corp (CNTQ) Files S-4 in Connection with Proposed Merger with Dragonfly Energy
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.

